Chemical Compound

Dihydroproscar

CAS Registry Number 98319-24-5
Back to search Request a Quote
Dihydroproscar chemical structure
Primary Record

Dihydroproscar

In stock
2,821 g
Purity
99.3 %
CAS
98319-24-5

Compound Identifiers & Properties

CAS
98319-24-5
PubChem CID
9864387
SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(CCC(=O)N4)C
Canonical SMILES
CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

Names & Synonyms

  • Dihydroproscar
  • Dihydro Finasteride
  • Dihydrofinasteride
  • 98319-24-5
  • Finasteride Impurity A
  • 1,2-Dihydrofinasteride
  • Finasteride EP Impurity A
  • YXO6UEY0UP
  • UNII-YXO6UEY0UP
  • RefChem:403148
  • MFCD00214352
  • Finasteride impurity A [EP]
  • AMY189
  • SCHEMBL4019990
  • CHEMBL2298592
  • DTXSID40432068
  • ZOIUUCNFVDJSJK-WSBQPABSSA-N
  • C23H38N2O2
  • EBD13047
  • EX-A1946
  • ZINC5921125
  • AKOS025310135
  • ACN-043353
  • CB11414
  • CID9864387
  • CS-O-05487
  • FD21922
  • CID 9864387
  • NCGC00485347-01
  • AS-35368
  • BC201593
  • SC-17251
  • SY238867
  • 3-Oxo-4-aza-5-alpha-androstane-17-beta-N-t-butylcarboxamide
  • J695.696C
  • CS-0028581
  • D5693
  • FINASTERIDE IMPURITY A [EP IMPURITY]
  • (4AR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
  • A-2007
  • 319D245
  • A845839
  • F041355
  • 3-oxo-4-aza-5a-androstane-17beta-(n-t-butylcarboxamide)
  • N-t-Butyl-3-oxo-4-aza-5alpha-androst-17beta-carboxamide
  • (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,8,9,9b,10,11-tetradecahydroindeno[5,4-f]quinoline-1-carboxamide
  • 1H-Indeno[5,4-f]quinoline-7-carboxamide,N-(1,1-dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-,(4aR,4bS,6aS,7S,9aS,9bS,11aR)-
  • N-tert-butyl-3-oxo-4-aza-5?-androst-17?-carboxamide
  • 17beta-(tert-Butylcarbamoyl)-4-aza-5alpha-androstan-3-one
  • 3-Oxo-4-aza-5?-androstane-17?-(N-tert-butylcarboxamide)
  • 3-Oxo-4-aza-5|A-androstane-17|A-(N-t-butylcarboxamide)
  • 3-Oxo-4-aza-5a-androstane-17b-(N-tert-butylcarboxamide)
  • Finasteride Impurity A; Dihydro Finasteride; Dihydroproscar
  • N-(tert-Butyl)-3-oxo-4-aza-5-androstane-17-carboxamide
  • N-t-butyl-4-aza-5-alpha-Androsta-3-one-17beta-Carboxamide
  • 3-Oxo-4-aza-5-alpha-androstane-17-belta-N-t-butylcarboxamide
  • 3-OXO-4-AZA-5-ALPHA-ANDROSTANE-17-BETA-N-T-BUTYLCA
  • 3-oxo-4-aza-5a-androstane-17-beta-(n-tert-butylcarboxamide)
  • 3-Oxo-4-aza-5alpha-androstane-17beta-(N-t-butylcarboxamide)
  • F9:3-Oxo-4-aza-5a-androstane-17b-(N-tert-butylcarboxamide)
  • n-(1,1-dimethyl)-3-oxo-4-aza-5a-andro-stane-17b-carboxamide
  • N-(tert-Butyl)-3-oxo-4-aza-5|A-androstane-17|A-carboxamide
  • 3-OXO-4-AZA-5ALPHA-ANDROSTANE-17BETA-(N-T-BUTYL)CARBOXAMIDE
  • n-(1,1-dimethylethyl)-3-oxo-4-aza-5a-andro-stane-17b-carboxamide
  • N-(1,1-Dimethylethyl)-3-oxo-4-aza-5alpha-androstane-17beta-carboxamide (Dihydrofinasteride)
  • N-(tert-Butyl)-3-oxo-4-aza-5alpha-androstane-17beta-carboxamide
  • (2R,3R,4bS,6aS,7S,9aS,9bS)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
  • (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
  • (5,17)-N-(1,1-Dimethylethyl)-3-oxo-4-aza-androstane-17-carboxamide
  • (5|A,17|A)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrostane-17-carboxamide
  • 1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(1,1-dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)
  • 3-Oxo-4-aza-5|A-androstan-17|A-carboxylic acid N-(tert-butyl)amide
  • N-(1,1-Dimethylethyl)-3-oxo-4-aza-5alpha-androstane-17beta-carboxamide
  • 3-Oxo-4-aza-5alpha-androstane-17beta-(N-t-butylcarboxamide), >=90%, powder
  • N-(1,1-DIMETHYLETHYL)-3-OXO-4-AZA-5.ALPHA.-ANDROSTANE-17.BETA.-CARBOXAMIDE
  • (2r,3r,4bs,6as,7s,9as,9bs)-4a,6a-dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic ac
  • (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno(5,4-f)quinoline-7-carboxamide
  • (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-hexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
  • (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
  • (5|A,17|A)-N-(1,1-Dimethylethyl)-3-oxo-4-aza-androstane-17-carboxamide; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
  • [4aR-(4a|A,4b|A,6a|A,7|A,9a|A,9b|A,11a|A)]-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
  • 3-Oxo-4-aza-5alpha-androstane-17beta-(N-t-butylcarboxamide)/ Dihydroproscar/17|A-(t-Butylcarbamoyl)-4-aza-5a-androstan-3-one
  • 4a,6a,11a-trimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
  • 642-100-2
  • N-(1,1-Dimethylethyl)-3-oxo-4-aza-5alpha-androstane-17beta-carboxamide; Finasteride Imp. A (EP); Dihydrofinasteride; 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; 4-Azaandrostane-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5a,17ss)-; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide; 1,2-Dihydrofinasteride; 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-, [4aR-(4aa,4bss,6aa,7a,9ass,9ba,11ass)]-; 3-Oxo-4-aza-5a-androstan-17ss-carboxylic acid N-(tert-butyl)amide; N-(tert-Butyl)-3-oxo-4-aza-5a-androstane-17-carboxamide; N-(tert-Butyl)-3-oxo-4-aza-5a-androstane-17ss-carboxamide; Finasteride Impurity A